Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACROSS trial of roflumilast in COPD
ChiCTR-TRC-11001304Phase 3Completed
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Placebo with Roflumilast 500 ug (2 arms). Primary endpoint: FEV1. Started Mar 2011; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TRC-11001304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001304.